Budesonide 51333-22-3

97.5% up by HPLC, EP8.0 / GMP / DMF

Product categories

New Products

Product Details

Product Information

Product name	Budesonide
CAS No.	51333-22-3
Molecular Formula	C25H34O6
Molecular Weight	430.534
Quality Standard	97.5% up by HPLC, EP8/GMP/DMF
Appearance	White powder

COA of Budesonide

ITEMS	STANDARDS	RESULTS
Appearance	White or almost white crystalline powder	Almost white crystalline powder
Related substance	A≤0.2% D≤0.2% K≤0.2% L≤0.2% Total impurities≤0.5% Unspecified impurities≤0.1%	0.02% N.D. N.D. 0.18% 0.34% 0.07%
Epimer A	40.0%~51.0%	47.0%
Residual solvents	Methanol≤3000ppm Acetonitril≤410ppm Methylene Chloride≤600ppm Ethanol≤5000ppm Acetone≤5000ppm	N.D. N.D. 26ppm. 656ppm N.D.
Loss on drying	≤0.5%	0.14%
Assay	97.5%~102.0%	99.3%
Particle Size	----	99.3% 7.1μm 90.0% 4.6μm
Conclusion	Complies with the requirements of EP8.0

Usage

Function of Budesonide

1. Budesonide can suppress the immune response that occurs when asthma occurs

2. Reduce the irritation response of the airway

3. Relieve bronchial obstruction caused by allergic reactions

4. Contraction and expansion of mucosal blood vessels, reducing blood vessel tension

5. The role of fighting inflammation, especially chronic inflammation

6. Relieve asthma and breathing difficulties

7. Improve lung ventilation function

8. Effectively prevent asthma in adults and children

9. Pathological symptoms such as airway mucosal edema and thickening of epithelial basement membrane caused by chronic asthma

Budesonide is often used for nebulization treatment. The patient can inhale budesonide suspension to reduce phlegm and expectorant, relieve spasm and relieve asthma. In fact, nebulization is commonly used in respiratory and pediatrics, and the main population is the elderly and infants with poor sputum expectoration ability.

*Products under the patent are only for R&D use